Pacira BioSciences (FRA:82P) Preferred Dividends: €0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:82P Pacira BioSciences Inc FRA:82P
82 GF Score
Price €22.20
GF Value €25.59
! 8 Warning Signs
View Full Analysis

What is Pacira BioSciences Preferred Dividends?

Pacira BioSciences FRA:82P 82 Preferred Dividends is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:82P with a GF Score™ of 82/100 and a GF Value™ of €25.59. The stock has 8 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Pacira BioSciences's preferred dividends for the three months ended in Mar. 2026 was €0.0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Pacira BioSciences  (FRA:82P) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacira BioSciences Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Pacira BioSciences's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacira BioSciences Preferred Dividends Chart

Pacira BioSciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Preferred Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Pacira BioSciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:82P
82GF Score
Pacira BioSciences Inc FRA:82P
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacira BioSciences Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of €0.0 Mil mean?
Pacira BioSciences (FRA:82P) has a Preferred Dividends of €0.0 Mil as of Mar. 2026. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Pacira BioSciences and its competitors.
Is Pacira BioSciences' Preferred Dividends too high?
Pacira BioSciences' current Preferred Dividends is €0.0 Mil. Overall, Pacira BioSciences has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Pacira BioSciences' Preferred Dividends compare to ETON and AMPH?
Pacira BioSciences' Preferred Dividends of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Drug Manufacturers company?
A good Preferred Dividends depends on the Drug Manufacturers industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Pacira BioSciences and its competitors. Pacira BioSciences's current Preferred Dividends is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacira BioSciences stock overvalued right now?
Pacira BioSciences (FRA:82P) has a current Preferred Dividends of €0.0 Mil. The stock's GF Value™ is €25.59, compared to a current price of €22.20 — trading 13.2% below its estimated fair value. The current Preferred Dividends is €0.0 Mil. Pacira BioSciences' overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Pacira BioSciences (FRA:82P), the current Preferred Dividends is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacira BioSciences (FRA:82P) Overvalued in 2026?

Based on GuruFocus' analysis, Pacira BioSciences stock appears to be undervalued. The current stock price of €22.20 is trading 13.2% below its estimated GF Value™ of €25.59.

Key valuation signals for FRA:82P:

  • Preferred Dividends: €0.0 Mil
  • GF Value™: €25.59 vs. price of €22.20 (13.2% below fair value)
  • GF Score™: 82/100 with 8 warning signs

No single metric tells the full story. See the FRA:82P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pacira BioSciences Business Description

Other Exchanges PCRX:USA82P:Germany
Address 2000 Sierra Point Parkway, Suite 900, Brisbane, CA, USA, 94005
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
82GF Score

Get the complete analysis for FRA:82P

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.20
Price
€25.59
GF Value